Filing Details
- Accession Number:
- 0001438133-20-000130
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-08-12 18:43:44
- Reporting Period:
- 2020-08-10
- Accepted Time:
- 2020-08-12 18:43:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1438133 | Tandem Diabetes Care Inc | TNDM | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1238913 | D Kim Blickenstaff | C/O Tandem Diabetes Care, Inc. 11075 Roselle Street San Diego CA 92121 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-08-10 | 8,882 | $51.50 | 882,518 | No | 4 | M | Indirect | See Footnote |
| Common Stock | Disposition | 2020-08-10 | 4,248 | $103.34 | 878,270 | No | 4 | S | Indirect | See Footnote |
| Common Stock | Disposition | 2020-08-10 | 4,134 | $104.32 | 874,136 | No | 4 | S | Indirect | See Footnote |
| Common Stock | Disposition | 2020-08-10 | 500 | $104.85 | 873,636 | No | 4 | S | Indirect | See Footnote |
| Common Stock | Acquisiton | 2020-08-10 | 2,686 | $51.50 | 876,322 | No | 4 | M | Indirect | See Footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Indirect | See Footnote |
| No | 4 | S | Indirect | See Footnote |
| No | 4 | S | Indirect | See Footnote |
| No | 4 | S | Indirect | See Footnote |
| No | 4 | M | Indirect | See Footnote |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2020-08-10 | 11,568 | $0.00 | 11,568 | $51.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 159,210 | No | 4 | M | Direct |
Footnotes
- Represents shares of common stock received upon exercise of a stock option award.
- The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010.
- The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $102.72 to $103.69. The Reporting Person undertakes to provide the Securitiesand Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
- The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $103.78 to $104.72. The Reporting Person undertakes to provide the Securitiesand Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
- The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $104.79 to $104.87. The Reporting Person undertakes to provide the Securitiesand Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
- The option vested as to twenty-five percent (25%) of the underlying shares on 02/15/2020, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter.
- The expiration date for these options is 10 years from the date of grant.
Billionaire Hedge Funds
